Bain Capital Public Equity Management’s Merck MRK Stock Holding History

Bain Capital Public Equity Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,890	Closed	-$1.77M	–	67
2017 Q1	$1.77M	Buy	+12,890	New	+$782K	0.13%	55
2016 Q4	–	Sell	-17,507	Closed	-$4.89M	–	61
2016 Q3	$4.89M	Buy	+17,507	New	+$1.02M	0.32%	28

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bain Capital Public Equity Management's MRK Position: Q3 2018 in Review

Bain Capital Public Equity Management sold out of Merck (MRK) in Q3 2018, closing a stake of 250,656 shares — an estimated $11.8M sold.

Bain Capital Public Equity Management first reported a position in MRK in Q3 2016 and held it in 5 quarters. The position peaked at $127M in Q3 2016. 2,057 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

Bain Capital Public Equity Management reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
Bain Capital Public Equity Management sold 250,656 Merck shares in Q3 2018, an estimated $11.8M.
Bain Capital Public Equity Management first reported a position in Merck in Q3 2016 and held it in 5 quarters.
Bain Capital Public Equity Management's Merck position peaked at $127M in Q3 2016.
2,057 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.